CIK 0001639691 · Large accelerated filer
LivaNova PLC
Sign in to watch- Ticker
- LIVN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981268150
- Phone
- 4402033250660
- Business address
- 5220 VALIANT COURT, GLOUCESTER BUSINESS PARK, GLOUCESTER, United Kingdom
- Former names
- Sand Holdco Plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $819,115
- in 4 filings, $227K under 10b5-1 plans
Net −$819,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-15 | Barry James Christopher Director | Option exercise | +1,709 | 1,709 | ||
| 2024-12-15 | Barry James Christopher Director | Shares withheld for taxes | −353 | $51.50 | $18K | 1,356 |
| 2024-12-15 | Barry James Christopher Director | Option exercise · Restricted Stock Units | −1,709 | 0 | ||
| 2024-12-15 | Shvartsburg Alex Chief Financial Officer | Option exercise | +613 | 19,342 | ||
| 2024-12-15 | Shvartsburg Alex Chief Financial Officer | Shares withheld for taxes | −229 | $51.50 | $12K | 19,113 |
| 2024-12-15 | Shvartsburg Alex Chief Financial Officer | Option exercise · Restricted Stock Units | −613 | 0 | ||
| 2024-12-15 | PODLOGAR SUSAN M Director | Grant or award · Restricted Stock Units | +2,355 | 2,355 | ||
| 2024-12-11 | Bianchi Francesco Director | Sale | −1,250 | $50.99 | $64K | 7,522 |
| 2024-09-15 | Poletti Franco President, Cardiopulmonary | Grant or award · Restricted Stock Units | +2,575 | 2,575 | ||
| 2024-09-15 | Poletti Franco President, Cardiopulmonary | Grant or award · Performance Stock Units | +1,287 | 1,287 | ||
| 2024-09-15 | Poletti Franco President, Cardiopulmonary | Grant or award · Performance Stock Units | +1,287 | 1,287 | ||
| 2024-09-15 | Poletti Franco President, Cardiopulmonary | Grant or award · Performance Stock Units | +2,575 | 2,575 | ||
| 2024-09-15 | Poletti Franco President, Cardiopulmonary | Grant or award · Stock Appreciation Rights | +5,885 | 5,885 | ||
| 2024-09-11 | Bianchi Francesco Director | Sale | −1,500 | $46.58 | $70K | 8,772 |
| 2024-06-15 | Barry James Christopher Director | Grant or award · Restricted Stock Units | +3,416 | 3,416 | ||
| 2024-06-15 | WILVER PETER M Director | Option exercise | +2,680 | 4,317 | ||
| 2024-06-15 | WILVER PETER M Director | Shares withheld for taxes | −585 | $52.68 | $31K | 3,732 |
| 2024-06-15 | WILVER PETER M Director | Option exercise · Restricted Stock Units | −2,680 | 0 | ||
| 2024-06-15 | WILVER PETER M Director | Grant or award · Restricted Stock Units | +3,416 | 3,416 | ||
| 2024-06-15 | Tezel Ahmet Chief Innovation Officer | Grant or award · Restricted Stock Units | +11,863 | 11,863 |
Page 13 of 25 · 489 trades